SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper
-
- Target Alle SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper anzeigen
- SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)
-
Reaktivität
- Coronavirus (CoV)
-
Wirt
-
Human
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
- Applikation
- Bitte anfragen
- Produktmerkmale
- Antibody recognizes 2019-nCoV Nucleocapsid Protein
- Isotyp
- IgG1
- Top Product
- Discover our top product SARS-CoV N Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 5 mg/mL
- Buffer
- PBS, pH 7.4, 0.09 % sodium azide (Sodium azide)
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 24 months from manufacturing at -20°C, 1 month, 2 to 8°C under sterile conditions.
-
- Target
- SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)
- Andere Bezeichnung
- Coronavirus Nucleocapsid Protein (SARS-CoV N Produkte)
- Substanzklasse
- Viral Protein
- Hintergrund
- Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
-